- 23109751OWN - NLMSTAT- MEDLINEDA  - 20121030DCOM- 20130410LR  - 20141104IS  - 1526-6702 (Electronic)IS  - 0730-2347 (Linking)VI  - 39IP  - 5DP  - 2012TI  - Implantation of left ventricular assist device complicated by undiagnosed      thrombophilia.PG  - 615-7AB  - A patient with dilated cardiomyopathy and no history of thromboembolic events      received a surgically implanted axial-flow left ventricular assist device. After       implantation, transesophageal echocardiography revealed a giant thrombus on the      lateral and anterior aspects of the left ventricle. The inflow cannula inserted      through the apex of the left ventricle was not obstructed, and the device      generated satisfactory blood flow. Laboratory screening for thrombophilia showed       protein S deficiency, heterozygous factor V Leiden mutation, and heterozygous      MTHFR C667T mutation. During the entire duration of circulatory support, no      significant suction events were detected, and the patient was listed for heart      transplantation. Ventricular assist device implantation can unmask previously      undiagnosed thrombophilia; therefore, it should be necessary to identify      thrombophilic patients before cardiac support implantation.FAU - Szarszoi, OndrejAU  - Szarszoi OAD  - Department of Cardiovascular Surgery, Institute for Clinical and Experimental      Medicine, 140 21 Prague 4, Czech Republic. onsz@medicon.czFAU - Maly, JiriAU  - Maly JFAU - Turek, DanielAU  - Turek DFAU - Urban, MarianAU  - Urban MFAU - Skalsky, IvoAU  - Skalsky IFAU - Riha, HynekAU  - Riha HFAU - Maluskova, JanaAU  - Maluskova JFAU - Pirk, JanAU  - Pirk JFAU - Netuka, IvanAU  - Netuka ILA  - engPT  - Case ReportsPT  - Journal ArticlePL  - United StatesTA  - Tex Heart Inst JJT  - Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's      Episcopal Hospital, Texas Children's HospitalJID - 8214622RN  - 0 (factor V Leiden)RN  - 9001-24-5 (Factor V)RN  - EC 1.5.1.20 (MTHFR protein, human)RN  - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2))RN  - Thrombophilia, hereditarySB  - IMMH  - Cardiomyopathy, Dilated/*complications/physiopathologyMH  - DNA Mutational AnalysisMH  - Echocardiography, Doppler, ColorMH  - Echocardiography, Doppler, PulsedMH  - Echocardiography, TransesophagealMH  - Factor V/geneticsMH  - Fatal OutcomeMH  - Genetic Predisposition to DiseaseMH  - Genetic Testing/methodsMH  - Heart Diseases/blood/*etiology/genetics/ultrasonographyMH  - Heart Failure/etiology/physiopathology/*therapy/ultrasonographyMH  - Heart-Assist Devices/*adverse effectsMH  - HumansMH  - MaleMH  - Methylenetetrahydrofolate Reductase (NADPH2)/geneticsMH  - Middle AgedMH  - MutationMH  - Predictive Value of TestsMH  - Prosthesis DesignMH  - Prosthesis-Related Infections/etiologyMH  - Protein S Deficiency/complications/diagnosis/geneticsMH  - Stroke VolumeMH  - Thrombophilia/blood/*complications/diagnosis/geneticsMH  - Thrombosis/blood/*etiology/genetics/ultrasonographyMH  - *Ventricular Function, LeftPMC - PMC3461681OID - NLM: PMC3461681OTO - NOTNLMOT  - Anticoagulants/therapeutic useOT  - blood coagulation disorders/complicationsOT  - factor V LeidenOT  - factor V/geneticsOT  - left ventricular assist deviceOT  - perioperative careOT  - postoperative complicationsOT  - thrombophilia/geneticsOT  - thrombus/etiology/prevention & controlEDAT- 2012/10/31 06:00MHDA- 2013/04/11 06:00CRDT- 2012/10/31 06:00PST - ppublishSO  - Tex Heart Inst J. 2012;39(5):615-7.